Now I have a thorough understanding of the paper. Let me produce the final consolidated review.

## Summary

This paper formulates PPI candidate ranking as a distinct problem — given a target protein and its known interactors, rank novel candidates for experimental validation. The authors propose a two-stage pipeline: (1) interpretability-guided retrieval that extracts "activated" embedding regions from D-SCRIPT/Topsy-Turvy predicted contact maps and computes cosine similarity to known partners as a ranking score, and (2) re-ranking of the top candidates using interaction scores, structural plausibility (pDockQ), annotation overlaps, and LLM-based semantic signals. Evaluation uses a prospective temporal split (STRING v11→v12) where models trained on v11 are tested on novel v12 interactions.

## Strengths

- **Prospective temporal evaluation with consecutive STRING releases.** Training on v11 and testing exclusively on novel v12 interactions (disjoint from training data) rigorously measures whether computational methods anticipate future experimental discoveries. This design is rare in the PPI literature and stronger than the typical static/retrospective split.

- **Interpretability-guided retrieval produces large early-ranking improvements over raw interaction scores.** In Table 1, for D‑SCRIPT, Recall@10 rises from 1.24 % (prediction probability) to 26.41 % (ours), and MRR from 0.034 to 0.169 — roughly 20× and 5× improvements respectively. Even accounting for the asymmetric comparison (below), the magnitude indicates that focusing similarity computations on contact-map-activated residues provides a substantially better signal for candidate ranking than the model's own interaction probability.

- **Systematic comparison of nine re-ranking signals.** Table 2 provides a pairwise rank-shift analysis across diverse signals (interaction scores, pDockQ, TF‑IDF, token/location/key‑term overlaps, and three LLM encoders). This goes beyond showing that re-ranking "works" — it quantifies which evidence sources contribute most. The finding that PubMedBERT re-ranking improves/maintains 75.5 % of rediscoveries while pDockQ achieves only 47.2 % is actionable guidance for practitioners.

- **Model-agnostic framework tested on two backbones.** The retrieval pipeline is applied to both D‑SCRIPT and Topsy‑Turvy with consistent gains, demonstrating the approach is not tied to a single architecture.

## Weaknesses

### Fatal
None.

### Major

- **The baseline comparison is asymmetric: "Prediction Probability" baselines do not use known partners, while the proposed method does.** The paper compares its interpretability-guided approach (which uses known partners \(KP(p)\) as anchors) against the raw D‑SCRIPT/Topsy‑Turvy interaction probability for each candidate pair — a signal that completely ignores known interactors. By construction, a method that leverages known partners should outperform one that does not. The experimental design cannot disentangle whether the improvement comes from (a) simply having access to known partners at all, versus (b) the specific *active-region* similarity computation. A critical missing baseline is a simple known-partner signal — e.g., ranking candidates by average cosine similarity of full (non-activated) embeddings to known partners, or by max/average interaction score with known partners. Without such a control, the paper's central claim that the *specific design choices* (interpretability-guided active regions, re-ranking signals) drive the improvement is not convincingly supported. This is the most significant weakness and limits the strength of the conclusions that can be drawn.

- **MAP values equal Recall values at all cutoffs ≥ 50 for most rows in Table 1, without explanation.** For D‑SCRIPT and Topsy‑Turvy rows (both Prediction Probability and Our Approach), MAP@k and Recall@k are identical to four decimal places for k ∈ {50, 100, 200, 500}. This pattern does not occur for xCAPT5 (where MAP and Recall always differ). While MAP and Recall are different metrics with different definitions, and can theoretically coincide under specific conditions (e.g., one relevant item per query always retrieved at rank 1), the systematic convergence at larger cutoffs across multiple methods is unexplained and suspicious. The paper must clarify the definition used and confirm the computation is correct. At k=5 and k=10 the values do differ (contradicting the harsh critic's claim that they are identical "across every row and cutoff"), so the column is not simply mislabeled, but the convergence needs a rigorous explanation.

- **Re-ranking analysis lacks end-to-end evaluation.** The re-ranking evaluation (Table 2) reports only *pairwise rank-shift fractions* — i.e., what fraction of true novel interactions maintain or improve their rank relative to a baseline ordering. This does not demonstrate that the *final ranking* after re-ranking has better recall@k, nDCG, or MRR than the initial embedding-based ranking. It is possible for a large fraction of true positives to shift upward while others drop, leaving overall recall@k unchanged or even worse. The paper claims the re-ranking module "is crucial to refine the initial embedding-based ranking" (Abstract, Section 4) but provides no end-to-end metric (e.g., recall@k, nDCG@k, or MRR for the final ranking after re-ranking) to substantiate this. This is a notable evidential gap.

- **The claim of "improving ranking metrics by two orders of magnitude" is not supported by the reported numbers.** The most dramatic improvement in Table 1 is D‑SCRIPT Recall@10 (0.0124 → 0.2641, approximately 21×, or ~1.3 orders of magnitude). MRR improves roughly 5×. "Two orders of magnitude" implies ~100× improvement. The paper should either provide a specific metric and cutoff that achieves 100× improvement, or correct the phrasing to reflect the actual magnitude.

### Minor

- **The criterion for "highly activated" residues in active region selection is not specified.** Section 4.1 states: "scan the resulting activation profile … identify all maximal contiguous segments of highly activated residues" but never defines the threshold or decision rule for classifying a residue as "highly activated." This is central to the method's reproducibility. The text says details are in Appendix A.1, but the main text should at least summarize the threshold criterion or the algorithm used.

- **It is unclear whether ranking metrics are computed over the full set of novel interactions or only the subset each model can score.** The "Pred. Cov." column reports values below 1.0 (e.g., 0.8088 for xCAPT5), but the paper does not explicitly state whether Recall, Precision, MAP, etc. are computed on the covered subset or the full set, treating unscored pairs as missed (rank = ∞). This ambiguity affects the fairness of cross-method comparisons. The paper should clarify this and ideally report both conditional and unconditional metrics.

- **"Two orders of magnitude" claim in the Abstract and Section 6.** As noted in Major above, this is unsupported by the data and should be corrected.

- **Topsy-Turvy Prediction Probability Recall@10 = 0.00117** (Table 1). This value is an order of magnitude smaller than the k=5 value (0.0063) and the k=50 value (0.0639), producing a non-monotonic trend. This may be a typo or a data artifact; the authors should verify and explain.

- **Cross-encoder training lacks basic reporting statistics.** The fine-tuned PubMedBERT cross-encoder is central to the re-ranking analysis, but the paper provides no information about the number of training pairs, validation performance, training epochs, or hyperparameters in the main text. These may be in the removed appendix, but given the model's role in the rank-shift analysis, some summary statistics should be in the main paper.

- **Table 2 caption** mentions "† … and ‡ is reported" but the table shows only one number per cell. This appears to be a formatting artifact.

### Trivial

- Section 3 contains a garbled sentence: "One of the most widely adopted An example is the Bepler & Berger model."
- Section 4 contains "we design **a the** two-stage framework."
- Table 1 places the "Model" column at the far right, making it easy to misread which rows belong to which method. A label column on the left would improve readability.
- The "Prediction Coverage" metric is defined as a "total number" but the table values (0.8088–0.9683) are proportions, not counts.

## Nice-to-Haves

- Add a baseline that uses known partners in a simple manner (e.g., full-embedding cosine similarity averaged over known partners, or max interaction probability with any known partner). This would isolate whether the active-region selection provides additional benefit beyond simply using known partners at all.
- Report end-to-end ranking metrics (recall@k, nDCG@k, MRR) for the best-performing re-ranking strategy versus the initial cosine ranking, to substantiate the claim that re-ranking refines prioritization.
- Stratify results by the number of known partners per target, as performance likely degrades for proteins with very few known partners — this limitation is acknowledged qualitatively but not quantified.
- Include statistical significance measures (e.g., paired bootstrap for MRR/recall comparisons).
- Report cross-encoder classification performance (AUC/accuracy on held-out v11 data) to help gauge whether it learns meaningful functional similarity rather than exploiting training-data leakage patterns.

## Removed Points

These points were identified in the inputs but are removed or demoted for the following reasons:

- **"MAP column is almost certainly mislabeled"** — removed as stated. The values differ at k=5 and k=10 (e.g., D‑SCRIPT PP: Recall=0.0071 vs MAP=0.0103), so the column is not simply a copy of Recall. The convergence at larger cutoffs is a genuine concern retained as a Major weakness, but the claim of "identical across every row and cutoff" is factually incorrect.
- **"Evaluation is performed only on the subset of novel interactions"** — weakened to Minor. This is a valid ambiguity, but the paper does not confirm this and the claim is speculative. Retained as a clarity concern.
- **"D-SCRIPT selection for re-ranking not rigorously justified"** — removed. Table 1 shows D‑SCRIPT has higher MRR (0.1685 vs 0.0925), Precision, MAP, nDCG, and Success at early cutoffs compared to Topsy‑Turvy. The paper provides a reasonable justification.
- **Section-by-section typos, formatting concerns, and requests for appendix content** — these are minor or parser-artifact issues. Relevant ones are folded into Trivial or Minor above.
- **"Missing related works"** — not permitted per merger rules.
- **Reproducibility complaints about hyperparameters/implementation details** — removed; these are standard for papers with appendices.
- **Strength Finder's generic strengths** (e.g., "important problem," "interesting question") — removed as lacking specificity. Only concrete, evidence-backed strengths are retained.

## Novel Insights

None beyond the paper's own contributions. The core insight — that focusing similarity computations on contact-map-activated residues from known interactions substantially improves candidate ranking — is the paper's main contribution. The comparative analysis of re-ranking signals (semantic > structural for this task) is a secondary but useful finding.

## Suggestions

1. Add a simple known-partner baseline (full-embedding cosine similarity averaged across known partners) to isolate the benefit of active-region selection.
2. Clarify the MAP computation and explain why MAP = Recall at cutoffs ≥ 50 for most methods.
3. Report end-to-end metrics for the best re-ranking strategy (e.g., PubMedBERT) compared to the initial cosine ranking — not just rank-shift fractions.
4. Replace "two orders of magnitude" with precise improvement ratios (e.g., "up to 21× improvement in Recall@10").
5. Specify the threshold or algorithm used to define "highly activated" residues in active region selection.
6. State explicitly whether metrics are computed on the full novel-pair set or only the covered subset, and clarify the relationship between "Pred. Cov." and the other metrics.

## Score and Decision

MY FINAL SCORE: <score>4.5</score>
MY FINAL DECISION: <decision>Reject</decision>